Evidence map›Paper›PMID 24854263›Full record

SynthesisJournal of the American Society of Nephrology : JASN2014

Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia.

Saima Aslam, Florin Vaida, Michele Ritter, Ravindra L Mehta

Registry-linked trialOpen access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of the American Society of Nephrology : JASN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05248620 (Prophylactic Antibiotic Treatment in End Stage Kidney Disease and Central Venous Catheter as Hemodialysis Vascular Access), which is not on this map. Cited by 33 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 5 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05248620 narecruitingnot on this mapstarted 2022, after this paper: background citation

Prophylactic Antibiotic Treatment in End Stage Kidney Disease and Central Venous Catheter as Hemodialysis Vascular Access

TypeinterventionalSponsorZealand University HospitalRan2022 to 2029Enrolled800ConditionsHemodialysisArmsAmoxicillin Clavulanic 500/125mg or placebo
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 5 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Healthcare (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Saima AslamDivision of Infectious Diseases, Department of Medicine, saslam@ucsd.edu.
Florin VaidaDivision of Biostatistics and Bioinformatics, Department of Family and Preventive Medicine, and.
Michele RitterDivision of Infectious Diseases, Department of Medicine.
Ravindra L MehtaDivision of Nephrology, Department of Medicine, University of California, San Diego, California.
Office of Infectious Diseases · USGeneral Department of Preventive Medicine · VNUniversity of California, San Diego · US

Funding

Anti-Biofilm Strategies for Treating Infected Hemodialysis CathetersK23DK078828 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ASLAM, SAIMA · 2009 to 2013
$747k
NIDDK NIH HHS 7K23-DK078828NIDDK NIH HHS K23 DK078828
6 · The paper itself

Abstract

Hemodialysis catheter-related bacteremia is a common clinical problem with several management options. We performed a systematic review and meta-analysis to determine cure proportions with systemic antibiotics, antibiotic lock solution, and guidewire exchange. We searched databases and registries; conference proceedings from relevant medical societies; and article reference lists. Data regarding management approach, cure, follow-up, recurrence, complications, and microbiology were abstracted and pooled from 28 selected publications. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated from a mixed effects logistic regression model. In total, 1596 patients with tunneled hemodialysis catheter-related bacteremia were divided into groups on the basis of treatment with systemic antibiotics (n=697), antibiotic lock solution (n=546), or guidewire exchange (n=353). Antibiotic lock solution and guidewire exchange had similar cure proportions that were superior to systemic antibiotics alone (OR, 2.08; 95% CI, 1.25 to 3.45; P<0.01 for antibiotic lock solution; OR, 2.88; 95% CI, 1.82 to 4.55; P<0.001 for guidewire exchange versus systemic antibiotics). Cure proportions were highest for coagulase-negative staphylococci followed by gram-negative rods and Staphylococcus aureus. Among S. aureus infections, guidewire exchange led to a higher cure proportion than systemic antibiotics or antibiotic lock solution (OR, 3.33; 95% CI, 1.17 to 9.46; P=0.02; OR, 4.72; 95% CI, 1.79 to 12.46; P=0.002, respectively). Thus, results of this study suggest that tunneled hemodialysis catheter-related bacteremia should be treated with either guidewire exchange or antibiotic lock solution. Future studies should address prospectively whether one strategy is better than the other overall and for specific pathogens.

Indexed as

BacteremiaCatheterizationCatheters, IndwellingHumansLogistic ModelsOdds RatioRenal DialysisResearch DesignStaphylococcal InfectionsStaphylococcus aureusantibiotic lock solutionbacteremiaguidewire exchangehemodialysis

Identifiers

PMID24854263
PMCPMC4243345
OpenAlexW2145664621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.